Tools
Stock profile

UNIVERSAL HEALTH SERVICES INC (UHS)

UHS · Latest close $186.07 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$186.07
As of Nov 18, 2026
Tracked funds holding
3 of 149
2026 Q2 13F filings
Opened / added
1 / 2
vs previous quarter
Trimmed / exited
0
vs previous quarter

UNIVERSAL HEALTH SERVICES INC (UHS) is held by 3 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund opening new positions and 2 funds adding versus the previous quarter. Latest close $186.07 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

First Eagle Investment Management · Pzena Investment Management · Carronade Capital Management — 3 tracked funds hold UHS. See all holders.

Insider and Congress activity

No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.

Often held alongside

HCA Healthcare, Inc. (HCA) · TENET HEALTHCARE CORP (THC) · Surgery Partners, Inc. (SGRY) · Natera, Inc. (NTRA) · Guardant Health, Inc. (GH) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
First Eagle Investment Management1.11%4,554,670ADDED (+2.9%) Q3 filed Nov 10
Pzena Investment Management0.86%1,969,327ADDED (+3.0%) Q3 filed Oct 30
Carronade Capital Management0.51%200,000NEW Q3 filed Nov 16

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +27.5% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

244.18137.052024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding594 of 8,857 filers
Long-only filers among them593
Change vs 2026 Q1-49 net · 544 entered · 593 exited
Shares reported, all filers52,141,271
Reported value, all filers$7.5B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryServices-General Medical & Surgical Hospitals, NEC (SIC 8062)
Revenue · FY2025$17.4B
Net income · FY2025$1.5B
Total assets · FY2025$15.5B
Shares outstanding63,581,000
Market cap (at latest close)$11.8B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Dec 31, 2025.

Short interest

Shares short · Oct 15, 20262,639,156
Share of shares outstanding4.15%
Days to cover4.87

Shares short at recent settlements — Jul 31, 2026: 3.0M · Aug 14, 2026: 2.6M · Aug 31, 2026: 2.6M · Sep 15, 2026: 2.7M · Sep 30, 2026: 2.6M · Oct 15, 2026: 2.6M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Dec 31, 2025.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 4 · Aug 14, 2026: 0 · Aug 31, 2026: 2K · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Dec 31, 2025.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Mar 13, 2026ELLIOT SUSSMANDirector356$68.8KMar 13, 2026SEC filing
Mar 11, 2026ELLIOT SUSSMANDirector318$59.3KMar 11, 2026SEC filing
Nov 12, 2025WARREN NIMETZDirector3,817$852.3KNov 11, 2025SEC filing
Oct 29, 2025ELLIOT SUSSMANDirector965$217.8KOct 29, 2025SEC filing
Mar 10, 2025MARIA RUDERMAN SINGERDirector1,000$179.2KMar 10, 2025SEC filing
Dec 11, 2024MARIA RUDERMAN SINGERDirector1,614$308.5KDec 11, 2024SEC filing
Aug 13, 2024ELLIOT SUSSMANDirector1,722$375.5KAug 13, 2024SEC filing
Aug 12, 2024WARREN NIMETZDirector3,444$749.6KAug 12, 2024SEC filing
Jul 26, 2024ELLIOT SUSSMANDirector2,541$533.6KJul 26, 2024SEC filing
Jul 26, 2024EILEEN C. MCDONNELLDirector2,535$531.2KJul 26, 2024SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Aug 6, 2026First Eagle Investment Management, LLCSC 13G/A4,674,801.248.8%Jun 30, 2026SEC filing
Apr 30, 2026Vanguard Capital ManagementSC 13G3,922,9267.3%Mar 31, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Apr 17, 2025BlackRock, Inc.SC 13G/A4,139,5317.2%Mar 31, 2025SEC filing
Feb 5, 2025BlackRock, Inc.SC 13G/A5,001,9068.5%Dec 31, 2024SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Services-General Medical & Surgical Hospitals, NEC (SIC 8062). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 46 Lobbying Disclosure Act filings named this company as client, 1999–2026; most common issues: Health Issues (36), Medicare/Medicaid (7), Insurance (1).

Federal contracts: no obligated amounts found for this ticker (USASpending, fiscal years 2021–2026).

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Growth — Revenue up every year for 5 straight years

· Lynch PEG — Cheap against its growth rate

· Dividend Growth — Dividends raised for more than 10 years

· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%

· Neff Total Return Ratio — Growth plus dividends divided by P/E is high

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Shareholder Yield — Cash returned through dividends and buybacks

· Earnings Stability — Small earnings swings and almost no loss years

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

Key figures

· Growth — Latest revenue: $17.4B · 5-yr revenue CAGR: 8.5% · Straight growth years: 9

· Lynch PEG — P/E: 7.65 · 5-yr EPS growth: 16.0% · PEG: 0.48

· Dividend Growth — Dividend per share: 0.80 · Dividend yield: 0.4% · Straight dividend years: 13 · 10-yr dividend growth: 33.3%

· Cash Flow (FCF) — Latest FCF: $849.2M · FCF yield: 7.5% · Positive FCF years: 3

· Neff Total Return Ratio — EPS growth: 16.0% · Dividend yield: 0.4% · P/E: 7.65 · Neff ratio: 2.15

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.61 · Operating cash flow: $1.9B · Net income: $1.5B

· Shareholder Yield — Shareholder yield: 8.5% · of which dividends: 0.0% · of which buybacks: 8.5%

· Earnings Stability — Earnings variation (CV): 0.27 · Loss years (of 10): 0 · Latest net income: $1.5B

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Share count tripled (3x)1100.0%+3.9%+2.9%+1.0%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold UHS — ranked by lift, the co-holding pattern described in Methodology: HCA Healthcare, Inc. (HCA) · TENET HEALTHCARE CORP (THC) · Surgery Partners, Inc. (SGRY) · Natera, Inc. (NTRA) · Guardant Health, Inc. (GH) · Brookdale Senior Living Inc. (BKD) · Acadia Healthcare Company, Inc. (ACHC) · LABCORP HOLDINGS INC. (LH).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Oct 27, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Aug 21, 20261.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation · 9.01 Financial Statements and ExhibitsSEC filing
Aug 17, 20262.03 Creation of a Direct Financial Obligation · 8.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

HCA Healthcare, Inc. (HCA) · Track Record: how the signals scored · Practice timing on UHS

One email a week: the week’s new filings and research. Subscribe free

← UHAL  ·  UL →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.